Gaia C

Surgeon @IstTumori
#Colorectal Department

[Gaia C @CollGaia]

@GabrielaMoslein @AmCollSurgeons @EHTGtweets @escp_tweets Congratulations !!! 🎉

[Istituto Tumori @IstTumori]

Risonanza magnetica per cure su misura, all'@IstTumori, la Prof.ssa Gina Brown ha mostrato come la radiologia innovativa stia rivoluzionando la cura del tumore del retto, aprendo a terapie più personalizzate.
#Oncologia #Ricerca
info: https://t.co/Mre4zcSHzp

[DCRjournal @DCRjournal]

#DCRJournal Rectal Cancer Watch-and-Wait Management: Experience of 545 Patients From the US Rectal Cancer Research Group | https://t.co/uXlYa61cVI

[ESMO - Eur. Oncology @myESMO]

#ESMOGI25: Study findings show that #ctDNA is a stronger #biomarker than carcinoembryonic antigen to select patients with #ColorectalCancer who may benefit from metastasis-directed therapy.

Read more in the #ESMODailyReporter

🔗 https://t.co/P7FUy3FxZa

#CRC

[JAMA Surgery @JAMASurgery]

Improving shared decision-making in surgical care is associated with better patient-reported postoperative outcomes. https://t.co/LzG5dikCNZ

[Gaia C @CollGaia]

“Verbal discrimination is particularly insidious… frequently leaving victims to question whether they are overreacting”.

First step to solve a problem is to recognize it. But sometimes, even this is hard.

https://t.co/hihfL8ucAR

[JAMA Surgery @JAMASurgery]

Routine use of indocyanine green fluorescence imaging does not decrease the overall rate of anastomotic leak in laparoscopic colorectal surgery if low anterior resections are not included. https://t.co/hWhqIR4uk5

[Gaia C @CollGaia]

@colothrive last day.
And last but not least...@MIC_DIANA_IRCAD. MIND-BLOWING!

[Gaia C @CollGaia]

Colorectal Thrive Congress Day 2 @colothrive - a triad of very interesting presentations this morning. I saw scenes of my life flashing before me (both good and bad 😂). Lots of food for thought, one must never stop striving to improve. #fribourg #colorectalthrive2025

[Michel Adamina @MichelAdamina]

We are honored to have again with us the Queen of Radiology #THRIVE2025 @prof_gina_brown with her evidence-based, thought-provoking views on MRI led optimal staging and guidance of multimodal treatment.
- enlarged LN are promoting survival, NOT indicating radiotherapy
- neither encapsulated LN close to the mesotectum margin
- tumor deposit and EMVI DRIVE PROGNOSIS AND TREATMENT DECISION, not the current TNM classification which suffered from too many imprecisions
- MERCURY 3 trial opened to better inform clinical decision-making and improve patients' outcomes

[Gaia C @CollGaia]

After yesterday's incredibly interesting masterclass, we're all ready for the Colorectal Thrive Congress!
#colorectalthrive #congress #fribourg

[Mass General Surgery @MGHSurgery]

We are thrilled to announce that this year’s Ernest A. Codman Lectureship, the most anticipated annual lecture at Harvard’s Advances and Controversies in Colorectal Surgery course, will be delivered by Prof. Gabriela Moslein from Germany #byExpertsforExperts @GabrielaMoslein

[Arndt Vogel @ArndtVogel]

Intermittent or Continuous Panitumumab + FOLFIRI for RAS and BRAF WT CRC
@JCO_ASCO
https://t.co/z6tMwFjBnM
🔎IMPROVE phs-3
👉ORR 68.1% vs 61.2%,
👉mPFS 11.2 vs 17.5 mo, left-sided w/ delayed resistance
👉mOS 36.3 vs 35.1 mo
🧐Deescalation is feasible, less tox
@myESMO

[Gaia C @CollGaia]

Here in Ferrara today for this wonderful @SICOBoard event. Spreading the word! @3isac

[European Society of Coloproctology @escp_tweets]

Register now for the next ESCP Global Reach webinar!
🗓️ 16 December
🕑 13:00 CET / 14:00 GMT

https://t.co/9GG94ChdC3

[Wim Ceelen @WimCeelen]

New review paper - Pathophysiology of Peritoneal Metastasis @DemuytereJesse @sernst @ISSPP1 https://t.co/VX2NnQi8AA

[Gaia C @CollGaia]

See u soon!

[Gabrielle van Ramshorst, MD FECSM FEBS FSSO @GabrielleVanRam]

Colorectal Surgery in the older patient: reactive or proactive geriatric teams? Overview by Albert Wolthuis; great discussion moderated by @JimkhanMD and @GabrielaMoslein #ESSO43 #OncoAlert @ESSOnews @OncoAlert

[Gaia C @CollGaia]

#SICO congress 2024
#peritonealsurfacemalignancies unit

[Istituto Tumori @IstTumori]

Comunicati risultati del bando di ricerca #PNRR del
@MinisteroSalute
: finanziato con 1Mil. di € il gruppo di ricerca della S.S. #TumoriPeritoneali dell'Istitutto Nazionale dei Tumori di Milano, guidata dal dott. Marcello Deraco. Svilupperà terapia innovative nei #TumoriRari dell’appendice.
https://t.co/MAcgx7geeV